IL6 and colorectal cancer: The pronounced male predominance in liver (+ 8.4 DALY difference) and colorectal cancers (+ 5.1) aligns with evidence that androgen signaling potentiates adipokine-driven carcinogenesis—specifically, visceral adiposity in males enhances interleukin-6 production, promoting hepatic inflammation and colorectal adenoma progression [12].